Special Correspondent: Arun Sharma, Noida

Noida-based Kailash IVF has completed a landmark year in advanced reproductive medicine, emerging as a centre of excellence with outcomes that align with, and in some cases surpass, global benchmarks. Backed by cutting-edge technology, international clinical protocols, and a highly experienced team of specialists, the institute has strengthened patient trust while delivering consistent success in fertility treatment.


Over the past year, the centre has conducted a significant number of IVF cycles and performed nearly 150 embryo transfers. Notably, it has achieved clinical pregnancy rates ranging between 85% and 90%, reflecting a strong commitment to quality-driven, patient-centric care.


At the core of this achievement is a distinguished team of experts led by IVF specialist Dr Sakshi Chopra, along with senior fertility consultants, embryologists, gynecologists, and counselling professionals. Their collaborative and individualized treatment approach has proven instrumental in managing even the most complex infertility cases.


Chairperson of Kailash Healthcare, Dr Uma Sharma, described the milestone as a significant step forward, emphasizing the institution’s vision of combining clinical excellence with compassionate care to ensure the highest standards of treatment for every couple.


Director of the Noida centre, Dr Rini Sharma, underscored the importance of personalized fertility care, noting that the team has successfully treated challenging cases involving repeated IVF failures, poor ovarian reserve, and metabolic complications through tailored stimulation protocols and optimized clinical strategies.


Adding further insight, Centre Head Dr Monika Gupta highlighted a complex case where a patient with multiple failed IVF attempts and underlying medical issues achieved a successful pregnancy through a precision-driven, customized treatment plan—demonstrating the centre’s clinical expertise.


Managing Director of Kailash Healthcare, Dr Kartik Sharma, stated that the first year of Kailash IVF reflects a strong commitment to making fertility care more accessible, advanced, and compassionate, while maintaining affordability and trust.


Experts at the centre also point to a rising trend of infertility in India, driven by delayed parenthood, stress, sedentary lifestyles, poor diet, obesity, pollution, and hormonal disorders. Male infertility, accounting for nearly 30–40% of cases, has become a critical concern, reinforcing the need for equal evaluation of both partners.


To enhance outcomes, Kailash IVF has adopted advanced technologies such as time-lapse embryo monitoring, preimplantation genetic testing (PGT), advanced vitrification, AI-assisted embryo grading, and personalized ovarian stimulation protocols. These innovations have enabled more accurate embryo selection and improved clinical decision-making.


The centre treats a wide spectrum of conditions, including PCOS/PCOD, endometriosis, tubal blockages, diminished ovarian reserve, male infertility, recurrent pregnancy loss, and unexplained infertility.


Marking its first anniversary, Kailash IVF has also introduced a limited-per

iod offer, providing a single-cycle IVF package—including consultations, ultrasounds, and injections—at a cost of ₹1.35 lakh.
With its strong clinical performance and patient-first philosophy, Kailash IVF is rapidly establishing itself as a trusted destination for fertility care, offering renewed hope to couples aspiring to parenthood.